Atripla
Brand for: Efavirenz-emtricitab-tenofo df
My Prescription
Payment
Select pharmacy
$36.99
Print or send this coupon to your phone
CVSPowered byAbout Atripla
Drug Details
Atripla is a combination medication that includes three antiretrovirals: efavirenz, emtricitabine, and tenofovir. Designed for the treatment of HIV, Atripla works by reducing the amount of the virus in the body, thus helping the immune system function more effectively. By doing so, it decreases the risk of HIV-related complications, such as infections and cancer, and enhances the quality of life for individuals with HIV. This medication incorporates efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), along with emtricitabine and tenofovir, which are nucleoside reverse transcriptase inhibitors (NRTIs). Together, they prevent HIV from replicating. While Atripla is beneficial in managing HIV, it is not a cure. To minimize the risk of transmitting HIV, patients should continue their prescribed medication regimen and use effective barrier methods, such as condoms or dental dams, during sexual activities. Sharing personal items that may have come into contact with blood or bodily fluids, like needles or razors, should be avoided. It is important to consult healthcare professionals for personalized advice and information.
Atripla (Efavirenz-emtricitab-tenofo Df) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 600-200-300MG | 30 Tablets | $36.99 | $1.23 |
Atripla FAQs
Atripla was not discontinued, but its use has declined due to the development of newer HIV medications that offer improved safety profiles and fewer side effects. Additionally, newer treatments often involve fewer pills and have a lower risk of drug interactions. Healthcare providers may prefer these newer options for managing HIV effectively.
Atripla is a combination antiretroviral medication that was commonly used for the treatment of HIV. However, treatment guidelines have evolved, and newer medications with improved efficacy and fewer side effects are often preferred. While Atripla may still be prescribed in certain situations, healthcare providers typically consider newer options as first-line treatments. It is important for patients to consult with their healthcare provider to determine the most appropriate treatment regimen for their specific condition.
Atripla can be replaced by several alternative antiretroviral regimens, depending on the individual's specific health needs and the guidance of their healthcare provider. Some common alternatives include single-tablet regimens like Biktarvy, Triumeq, or Dovato, which also combine multiple antiretroviral medications into one pill. It's important for patients to consult with their healthcare provider to determine the most appropriate treatment option for their situation.
A common concern when taking Atripla is the potential for side effects, particularly central nervous system effects such as dizziness, drowsiness, and vivid dreams. Additionally, Atripla can cause liver problems and may affect kidney function. It is important for patients to have regular monitoring and to discuss any side effects or concerns with their healthcare provider.
During therapy with Atripla, clinical monitoring should include regular assessment of liver function tests, renal function, and lipid profiles. Monitoring for signs of central nervous system side effects, such as dizziness or mood changes, is also important. Additionally, periodic evaluation of viral load and CD4 cell count is recommended to assess the effectiveness of the treatment. Regular follow-up with a healthcare provider is essential to manage any potential side effects and ensure adherence to the therapy.